Jake S. O’Donnell
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 10
- T-cell and Retrovirus Studies 3
- Oncology 11
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 6
- Cancer Cells and Metastasis 2
- Co-authors
- Michele W.L. Teng (10 shared papers)Mark J. Smyth (10 shared papers)Georgina V. Long (2 shared papers)Richard A. Scolyer (2 shared papers)Stacey Allen (4 shared papers)Daniela Massi (2 shared papers)Mario Mandalà (2 shared papers)Heidi Harjunpää (2 shared papers)
- Journals
- OncoImmunology (3 papers)Seminars in Cancer Biology (2 papers)Clinical Cancer Research (1 paper)The Lancet Haematology (1 paper)The Lancet Microbe (1 paper)
- Partner nations
- AustraliaNetherlandsItaly
In The Last Decade
Jake S. O’Donnell
17 papers receiving 3.2k citations
Jake S. O’Donnell's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.8k
- Immunology 1.3k
- Cancer Research 292
- Pulmonary and Respiratory Medicine 512
- Molecular Biology 791
Countries citing papers authored by Jake S. O’Donnell
This map shows the geographic impact of Jake S. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake S. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake S. O’Donnell more than expected).
Fields of papers citing papers by Jake S. O’Donnell
This network shows the impact of papers produced by Jake S. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake S. O’Donnell. The network helps show where Jake S. O’Donnell may publish in the future.
Co-authors
The 25 scholars most cited alongside Jake S. O’Donnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer immunoediting and resistance to T cell-based immunotherapy Hit paper breakdown → | 2018 | 1294 |
| 2 | Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease Hit paper breakdown → | 2016 | 593 |
| 3 | Resistance to PD1/PDL1 checkpoint inhibition Hit paper breakdown → | 2016 | 433 |
| 4 | 2017 | 320 | |
| 5 | 2019 | 139 | |
| 6 | 2019 | 104 | |
| 7 | 2019 | 72 | |
| 8 | 2018 | 70 | |
| 9 | 2016 | 55 | |
| 10 | 2018 | 51 | |
| 11 | 2016 | 35 | |
| 12 | 2021 | 17 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2019 | 1 |
About Jake S. O’Donnell
Jake S. O’Donnell is a scholar working on Immunology, Oncology, Molecular Biology, Agronomy and Crop Science and Infectious Diseases, having authored 17 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (6 papers), T-cell and Retrovirus Studies (3 papers), Animal Disease Management and Epidemiology (3 papers), Vector-Borne Animal Diseases (2 papers), Cancer Cells and Metastasis (2 papers) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.3k citations), Cancer Research (292 citations), Pulmonary and Respiratory Medicine (512 citations) and Molecular Biology (791 citations). Jake S. O’Donnell has collaborated with scholars based in Australia, Netherlands and Italy. Frequent co-authors include Michele W.L. Teng, Mark J. Smyth, Georgina V. Long, Richard A. Scolyer, Stacey Allen, Daniela Massi, Mario Mandalà, Heidi Harjunpää, Jing Liu and Kazuyoshi Takeda. Their work appears in journals such as OncoImmunology, Seminars in Cancer Biology, Clinical Cancer Research, The Lancet Haematology and The Lancet Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.